HBM HOLDINGS-B

02142

10.5403.66% ( -0.400 )

Delay Closed: Nov 13, 16:08:17

Current ValuationThe current P/E ratio is 13.83, within the reasonable range, cheaper than 54.99% of the time in the past 3 years, and the industry ranks 12/78, the industry Median -5.30.

13.83xP/E

Stock priceHK$10.54Earnings per shareHK$0.76

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0154308462616

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09995HKREMEGEN	4.95x	512.28%	HK$37.65B
01530HK3SBIO	3.81x	71.78%	HK$36.30B
09969HKINNOCARE	12.93x	6.83%	HK$20.52B
02142HKHBM HOLDINGS-B	13.83x	8.46%	HK$9.16B
01167HKJACOBIO-B	5.97x	--	HK$3.53B
02509HKQYUNS-B	5.22x	23.95%	HK$3.28B
06998HKEDDING GENOR	12.09x	--	HK$3.05B
02197HKCLOVER BIO-B	2.21x	--	HK$2.16B
01061HKESSEX BIO-TECH	4.34x	1.60%	HK$1.15B
02566HKJIUYUAN GENE	6.27x	--	HK$1.01B
00690HKUNI-BIO GROUP	7.75x	--	HK$376.19M
08158HKCRMI	2.65x	--	HK$73.02M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.